患有性夜间血红蛋白尿症的患者的治疗负担:深入采访调查
Yasutaka Ueda1, Naoshi Obara2, Shikiko Ueno3
1Department of Hematology and Oncology, The University of Osaka Graduate School of Medicine, Osaka, Japan.
Annals of hematology
|July 18, 2025
概括
松性夜间血红蛋白尿症 (PNH) 治疗给患者带来了财务负担和时间的负担. 解决这些未满足的需求对于改善患者的生活质量以及治疗有效性至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药物经济学 药物经济学
背景情况:
- 阴性夜间血红蛋白尿 (PNH) 是一种严重的克隆性血液学疾病.
- C5抑制剂改善了PNH预后,是标准的护理.
- 扩大治疗选择需要了解患者报告的负担.
研究的目的:
- 调查患者报告的PNH护理负担.
- 确定影响PNH患者治疗选择的关键因素.
主要方法:
- 对30名PNH参与者进行了深入的患者访谈调查.
- 收集的数据主要集中在治疗经验,财务问题和与时间有关的负担上.
主要成果:
- 70%的患者接受了静脉注射C5抑制剂.
- 超过50%的人每月都要去医院看病,近一半的人错过了工作/上学.
- 财务问题,等待时间,旅行和花在护理上的时间是很大的负担.
结论:
- 目前的PNH护理存在着超出治疗有效性的持续负担.
- 时间和后勤挑战在PNH管理中代表了关键的未满足需求.
- 这些负担在治疗决策中必须与疗效一起考虑.
更多相关视频
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
320
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
320
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
260
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
260
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
226
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
226
Hemodialysis II: Procedure and Complications
138
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
138
Venous Thrombosis III: Interprofessional Care
23
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
23
Peritoneal Dialysis III: Nursing Management
149
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
149


